Boca Raton, FLNCT06867484Now EnrollingIRB Ready

Breast Cancer Clinical Trial in Boca Raton, FL

Access cutting-edge breast cancer treatment through this clinical trial at a research site in Boca Raton. Study-provided care at no cost to qualified participants.

Sponsored by Youssef Zeidan

Quick Self-Assessment

See if you qualify for this Boca Raton location

Preparing your pre-screening questions…

Expert Care in Boca Raton

Access breast cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related breast cancer treatment provided free

Apply for This Boca Raton Location

Check if you qualify for this breast cancer clinical trial in Boca Raton, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boca Raton

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boca Raton site if eligible
  4. 4Begin participation

About This Breast Cancer Study in Boca Raton

The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.

Sponsor: Youssef Zeidan

Who Can Participate

Inclusion Criteria

Diagnosed with ER+HER2- breast cancer
Provision of signed and dated ICF
Stated willingness to comply with all study procedures and availability for the duration of the study
Age ≥ 40 years
Oncotype \< 26 (postmenopausal) \<16 (premenopausal), Low, or Ultra-Low index.
Minimum interval of 18 months from last breast radiotherapy session.
Prior radiation therapy in the form of brachytherapy, external beam MV photons, protons or intraoperative radiation are allowed with an upper total dose limit of 68 Gy (EQD2) for those patients with prior records available.
Ipsilateral recurrence, unifocal \< 3 cm with negative margins, N0, Tis and invasive (pathological staging)
Eastern Cooperative Oncology Group (ECOG) ≤ 2
Planning target volume: whole breast (PTV: WB) ratio \< 1/2
Life expectancy \> 12 months
Individuals able to become pregnant: agreement to use highly effective contraception starting at screening through treatment, and for 1 year after the end of PBI. Should a participant become pregnant or suspect that they are pregnant while participating in this study, they should notify the treating physician immediately. A person able to become pregnant is any person assigned female at birth (regardless of gender identity, sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria:
Has not undergone a hysterectomy or bilateral oophorectomy; or
Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has not had menses at any time during the preceding 12 consecutive months)

Exclusion Criteria

BRCA1/2 mutation or any other receptor subtypes
Individuals assigned male at birth with breast cancer
Pregnancy or breastfeeding
Skin involvement
Distant metastasis
Patients with initial high-risk triple negative or HER-2 enriched breast cancer will be excluded from the trial. However, if the initial subtype is not known, patients will still be allowed to enroll, and the initial primary tumor information will be recorded as missing on the clinical forms.
Other malignancies (except skin)
Connective tissue disorder (e.g., scleroderma, lupus)
Any other condition that may put a participant at higher risk, at the discretion of the investigator.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boca Raton?

Yes, this clinical trial (NCT06867484) has an active research site in Boca Raton, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Breast Cancer Treatment Options in Boca Raton, FL

If you're searching for breast cancer treatment options in Boca Raton, FL, this clinical trial (NCT06867484) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boca Raton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all breast cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Boca Raton, FL

See all breast cancer clinical trials recruiting in Boca Raton — not just this study.

Browse Breast Cancer Trials in Boca Raton

Ready to Join in Boca Raton?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boca Raton, FL